Cargando…

The Concern of COVID-19 Vaccine Safety Is behind Its Low Uptake among Patients with Diabetes Mellitus in Sudan

Diabetic patients are vulnerable to developing severe complications and have a higher risk of death due to COVID-19 infection. Vaccination remains the mainstay during the current situation to mitigate the risks related to COVID-19 infection. Therefore, the aim of the current study was to assess the...

Descripción completa

Detalles Bibliográficos
Autores principales: Omar, Saeed M., Khalil, Rehana, Adam, Ishag, Al-Wutayd, Osama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031942/
https://www.ncbi.nlm.nih.gov/pubmed/35455276
http://dx.doi.org/10.3390/vaccines10040527
_version_ 1784692517210423296
author Omar, Saeed M.
Khalil, Rehana
Adam, Ishag
Al-Wutayd, Osama
author_facet Omar, Saeed M.
Khalil, Rehana
Adam, Ishag
Al-Wutayd, Osama
author_sort Omar, Saeed M.
collection PubMed
description Diabetic patients are vulnerable to developing severe complications and have a higher risk of death due to COVID-19 infection. Vaccination remains the mainstay during the current situation to mitigate the risks related to COVID-19 infection. Therefore, the aim of the current study was to assess the vaccination status and the factors associated with COVID-19 vaccine uptake among patients with diabetes mellitus (DM) in Sudan. A hospital-based cross-sectional study was conducted from January to February 2022 at Gadarif Hospital in eastern Sudan. Information on sociodemographics, the contracting of COVID-19 during the pandemic, beliefs toward COVID-19 vaccinations, and barriers related to COVID-19 vaccinations was obtained through an interview questionnaire among adult (≥18 years) patients with DM. Bivariate and multinomial logistic regression analyses performed. A total of 568 diabetic patients were enrolled, with a mean (SD) age of 53.07 (12.69) years. The majority of the participants were female (67.6%), urban residents (63.4%), uneducated (60.6%) and employed (73.2%). There was a history of COVID-19 in 97.4% of participants, and 29.2% of them had hypertension along with DM. About 31% received the vaccine, out of which 17.9% received the first dose, 13.2% received the second dose, and 0.2% received the third dose. Multinomial logistic regression analysis showed a significant association between belief in the safety of the COVID-19 vaccine and having had two doses of it (adjusted Odds ratio = 20.42, p < 0.001). The prevalence of COVID-19 infection was high, while the rate of COVID-19 vaccination uptake was low and inadequate among the participants. Appropriate health education and targeted interventions toward awareness of safety concerns are highly recommended.
format Online
Article
Text
id pubmed-9031942
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-90319422022-04-23 The Concern of COVID-19 Vaccine Safety Is behind Its Low Uptake among Patients with Diabetes Mellitus in Sudan Omar, Saeed M. Khalil, Rehana Adam, Ishag Al-Wutayd, Osama Vaccines (Basel) Article Diabetic patients are vulnerable to developing severe complications and have a higher risk of death due to COVID-19 infection. Vaccination remains the mainstay during the current situation to mitigate the risks related to COVID-19 infection. Therefore, the aim of the current study was to assess the vaccination status and the factors associated with COVID-19 vaccine uptake among patients with diabetes mellitus (DM) in Sudan. A hospital-based cross-sectional study was conducted from January to February 2022 at Gadarif Hospital in eastern Sudan. Information on sociodemographics, the contracting of COVID-19 during the pandemic, beliefs toward COVID-19 vaccinations, and barriers related to COVID-19 vaccinations was obtained through an interview questionnaire among adult (≥18 years) patients with DM. Bivariate and multinomial logistic regression analyses performed. A total of 568 diabetic patients were enrolled, with a mean (SD) age of 53.07 (12.69) years. The majority of the participants were female (67.6%), urban residents (63.4%), uneducated (60.6%) and employed (73.2%). There was a history of COVID-19 in 97.4% of participants, and 29.2% of them had hypertension along with DM. About 31% received the vaccine, out of which 17.9% received the first dose, 13.2% received the second dose, and 0.2% received the third dose. Multinomial logistic regression analysis showed a significant association between belief in the safety of the COVID-19 vaccine and having had two doses of it (adjusted Odds ratio = 20.42, p < 0.001). The prevalence of COVID-19 infection was high, while the rate of COVID-19 vaccination uptake was low and inadequate among the participants. Appropriate health education and targeted interventions toward awareness of safety concerns are highly recommended. MDPI 2022-03-29 /pmc/articles/PMC9031942/ /pubmed/35455276 http://dx.doi.org/10.3390/vaccines10040527 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Omar, Saeed M.
Khalil, Rehana
Adam, Ishag
Al-Wutayd, Osama
The Concern of COVID-19 Vaccine Safety Is behind Its Low Uptake among Patients with Diabetes Mellitus in Sudan
title The Concern of COVID-19 Vaccine Safety Is behind Its Low Uptake among Patients with Diabetes Mellitus in Sudan
title_full The Concern of COVID-19 Vaccine Safety Is behind Its Low Uptake among Patients with Diabetes Mellitus in Sudan
title_fullStr The Concern of COVID-19 Vaccine Safety Is behind Its Low Uptake among Patients with Diabetes Mellitus in Sudan
title_full_unstemmed The Concern of COVID-19 Vaccine Safety Is behind Its Low Uptake among Patients with Diabetes Mellitus in Sudan
title_short The Concern of COVID-19 Vaccine Safety Is behind Its Low Uptake among Patients with Diabetes Mellitus in Sudan
title_sort concern of covid-19 vaccine safety is behind its low uptake among patients with diabetes mellitus in sudan
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031942/
https://www.ncbi.nlm.nih.gov/pubmed/35455276
http://dx.doi.org/10.3390/vaccines10040527
work_keys_str_mv AT omarsaeedm theconcernofcovid19vaccinesafetyisbehinditslowuptakeamongpatientswithdiabetesmellitusinsudan
AT khalilrehana theconcernofcovid19vaccinesafetyisbehinditslowuptakeamongpatientswithdiabetesmellitusinsudan
AT adamishag theconcernofcovid19vaccinesafetyisbehinditslowuptakeamongpatientswithdiabetesmellitusinsudan
AT alwutaydosama theconcernofcovid19vaccinesafetyisbehinditslowuptakeamongpatientswithdiabetesmellitusinsudan
AT omarsaeedm concernofcovid19vaccinesafetyisbehinditslowuptakeamongpatientswithdiabetesmellitusinsudan
AT khalilrehana concernofcovid19vaccinesafetyisbehinditslowuptakeamongpatientswithdiabetesmellitusinsudan
AT adamishag concernofcovid19vaccinesafetyisbehinditslowuptakeamongpatientswithdiabetesmellitusinsudan
AT alwutaydosama concernofcovid19vaccinesafetyisbehinditslowuptakeamongpatientswithdiabetesmellitusinsudan